Clinical Trials
164 trialsPHL Treatment in Pancreatic Cancer
Fox Chase Cancer Center
GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer
University of Illinois at Chicago
DUMELEP
Assistance Publique - Hôpitaux de Paris
Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
ARETHUSA
IFOM ETS - The AIRC Institute of Molecular Oncology
FOBEAR
Sun Yat-sen University
Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial
Sun Yat-sen University
COnCERTO
University Hospital, Rouen
A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC
Tang-Du Hospital
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
Universitätsmedizin Mannheim
RESET
Sixth Affiliated Hospital, Sun Yat-sen University
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
PICC
Sun Yat-sen University
Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC
Sichuan Cancer Hospital and Research Institute
AB-LATE02
University Hospital, Montpellier
ESCC
Fujian Medical University Union Hospital
Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
Shanghai Zhongshan Hospital
Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer
Minia University
Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer
Changhai Hospital
NEONEC
GERCOR - Multidisciplinary Oncology Cooperative Group
Neo-CRAG
Sun Yat-sen University
STELLARIII
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
EUS-RFA PANCARDINAL-1 Trial
The University of Texas Health Science Center, Houston
NEOGB
Rajiv Gandhi Cancer Institute & Research Center, India
ADVANCE HCC
Ontario Clinical Oncology Group (OCOG)
NEEDS
Karolinska University Hospital
ESCC
Sichuan Cancer Hospital and Research Institute
NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC
RenJi Hospital
Neo-DRATEC
Zhejiang Cancer Hospital
Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial
Larissa University Hospital
ESOPEC
University Hospital Schleswig-Holstein
Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer
Sun Yat-sen University
Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer
St. James's Hospital, Ireland
A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCC
First Affiliated Hospital of Fujian Medical University
Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
University of Nebraska
CAIRO4
Dutch Colorectal Cancer Group
HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial
Sun Yat-sen University
TaLaR-02
Sun Yat-sen University
MSI-H/dMMR
Henan Cancer Hospital
Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
Eastern Cooperative Oncology Group
COLLISION RELAPSE Trial
Amsterdam UMC, location VUmc
HIPEC
National Cancer Institute, Naples
Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma.
Shandong Cancer Hospital and Institute
Randomized Clinical Trial on Preoperative Radiotherapy 25 Gy in Rectal Cancer
Jagiellonian University
Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma
Tata Memorial Hospital
WATCHER
Zhejiang Cancer Hospital
HCHTOG1903
Henan Cancer Hospital
Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer
ChineseAMS
CIFOXRC
Tongji Hospital